North America’s Wound Debridement Products Market Worth US$ 307.8 Million by 2024
Health risks of unattended wounds or undue exposure to infected tissues are becoming an alarming concern in the healthcare industry of North America. Ineffectiveness of conventional wound care products continues to impede the surgical improvement of patients being treated with infected diseases.
Health risks of unattended wounds or undue exposure to infected tissues are becoming an alarming concern in the healthcare industry of North America. Ineffectiveness of conventional wound care products continues to impede the surgical improvement of patients being treated with infected diseases.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>North</strong> America <strong>Market</strong> Study on <strong>Wound</strong><br />
<strong>Debridement</strong> <strong>Products</strong>: Chronic Ulcers Application<br />
Segment to Retain Its Dominance Through <strong>2024</strong>
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Report Media Releases<br />
<strong>North</strong> <strong>America’s</strong> <strong>Wound</strong> <strong>Debridement</strong> <strong>Products</strong> <strong>Market</strong><br />
Anticipated to Garner <strong>US$</strong> <strong>307.8</strong> <strong>Million</strong> <strong>by</strong> <strong>2024</strong><br />
Health risks of unattended wounds or undue exposure to infected tissues are becoming an<br />
alarming concern in the healthcare industry of <strong>North</strong> America. Ineffectiveness of conventional<br />
wound care products continues to impede the surgical improvement of patients being treated<br />
with infected diseases. In <strong>North</strong> America, growing expenditure on healthcare facilities and<br />
invasive surgeries compels medical organizations to improve recuperation processes such as<br />
tissue regeneration through the use of wound debridement products. According to a recent study<br />
undertaken <strong>by</strong> Persistence <strong>Market</strong> Research, total market revenues procured <strong>by</strong> sales of wound<br />
debridement products in <strong>North</strong> America are estimated to reach <strong>US$</strong> <strong>307.8</strong> million <strong>by</strong> the end of<br />
<strong>2024</strong>.<br />
Persistence <strong>Market</strong> Research’s report, titled “<strong>Wound</strong> <strong>Debridement</strong> <strong>Products</strong> <strong>Market</strong>: <strong>North</strong><br />
America Industry Analysis & Forecast, 2016-<strong>2024</strong>,” includes key findings that indicate <strong>North</strong><br />
<strong>America’s</strong> wound debridement products market to expand at a steady 6.9% CAGR<br />
throughout the forecast period 2016-2026. According to the report, an estimated <strong>US$</strong> 171.8<br />
million revenues have been attained in <strong>North</strong> America through wound debridement products<br />
sales in 2015. Over the projection period, a majority of <strong>North</strong> <strong>America’s</strong> wound debridement<br />
products revenues will be accounted <strong>by</strong> the US healthcare sector as Canada is anticipated to<br />
attribute just over 10% of the gross market value.<br />
Download Sample Report @ http://www.persistencemarketresearch.com/samples/12967<br />
Top Research Findings on <strong>North</strong> <strong>America’s</strong> <strong>Wound</strong> <strong>Debridement</strong> <strong>Products</strong> <strong>Market</strong><br />
In US, surging need for the application of wound debridement products in treatment of<br />
chronic ulcers is expected to account for the highest revenue share through <strong>2024</strong>.<br />
By the end of <strong>2024</strong>, the US wound debridement products market is projected to be<br />
valued over <strong>US$</strong> 250 million.<br />
On the other hand, the wound debridement products revenues attained from Canada are<br />
expected to exhibit an estimated <strong>US$</strong> 1.3 million increment in terms of revenues,<br />
between 2016 and 2017.<br />
Availability of a vast patient pool in <strong>North</strong> America serves as a favorable quotient for the<br />
growth of its wound debridement products market.<br />
Nevertheless, complications arising from Medical adhesive-related skin injury (MARSI) is<br />
projected to inhibit the growth in demand for wound debridement products in <strong>North</strong><br />
America.<br />
The growth of <strong>North</strong> <strong>America’s</strong> wound debridement products market has been analyzed on the<br />
basis of various types of products, considering their effectiveness, affordability and preference as<br />
key determinants of growth. In 2016 and beyond, mechanical debridement pads and traditional<br />
wound debridement devices will collective account for nearly 50% of the market revenues.<br />
Meanwhile, the market value share of surgical wound debridement devices is projected to drop<br />
from nearly 20% in 2016 to just over 15% <strong>by</strong> the end of <strong>2024</strong>.<br />
<strong>North</strong> America <strong>Wound</strong> <strong>Debridement</strong> <strong>Products</strong> <strong>Market</strong> <strong>by</strong> <strong>2024</strong>
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Throughout the forecast period, hospitals will retain as the dominant end-users of wound<br />
debridement products in <strong>North</strong> America. By the end of <strong>2024</strong>, revenues procured from wound<br />
debridement products sales to hospitals will be nearly 50% of the gross estimated revenues.<br />
ASCs and specialized clinics are expected to collectively garner over <strong>US$</strong> 100 million in<br />
revenues <strong>by</strong> <strong>2024</strong>-end, while wound debridement products sales accounted <strong>by</strong> <strong>North</strong> American<br />
nursing facilities will expand at a moderate CAGR of 4.6%. Increasing incidences of chronic<br />
ulcers in <strong>North</strong> America is projected to instrument the growth in demand for wound debridement<br />
products in hospitals. Revenues generated from the wound debridement products sales in<br />
chronic ulcers treatment across <strong>North</strong> American hospitals are expected to expand at an<br />
impressive 8.2% CAGR over the forecast period.<br />
Download Report Table of Content, Figures, and Tables @<br />
http://www.persistencemarketresearch.com/market-research/north-america-wounddebridement-products-market/toc<br />
Leading medical devices manufacturers in the US are recognized as some of the key players<br />
participating in the growth of wound debridement products market in <strong>North</strong> America. Companies<br />
such as Smith & Nephew PLC, Zimmer Biomet Holdings, Inc., Misonix, and Lohmann &<br />
Rauscher International are known for leading the market in terms of production of effective lowfrequency<br />
ultrasound wound debridement products. Derma Sciences Inc. holds an extended<br />
product portfolio for surgical wound debridement products and mechanical debridement pads,<br />
while BSN Medical specialized in traditional wound debridement and larval therapy products.<br />
Arobella Medical LLC, DeRoyal Industries Inc., and Söring GmbH are some other key<br />
manufacturers & suppliers of wound debridement products in <strong>North</strong> America.<br />
Browse Complete Report @ http://www.persistencemarketresearch.com/checkout/12967<br />
<strong>North</strong> America <strong>Wound</strong> <strong>Debridement</strong> <strong>Products</strong> <strong>Market</strong> <strong>by</strong> <strong>2024</strong>
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
About Us:<br />
Persistence <strong>Market</strong> Research (PMR) is a third-platform research firm. Our research model is a<br />
unique collaboration of data analytics and market research methodology to help businesses<br />
achieve optimal performance.<br />
To support companies in overcoming complex business challenges, we follow a multi-disciplinary<br />
approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying<br />
real-time data collection, big data, and customer experience analytics, we deliver business<br />
intelligence for organizations of all sizes.<br />
Our offerings include pre-built reports that address every major sale, customized solutions to<br />
cater to client-specific needs, and consulting services to offer more value addition. Our nextgeneration<br />
research approach for exploring emerging technologies has allowed us to solve the<br />
most complex problems of clients. We do not follow a reactive approach, but a pro-active one.<br />
Expert analysts at PMR keep a tab on next-generation technologies in their R&D phase and<br />
provide the latest insights into these technologies when they are being commercialized. Our<br />
ground-breaking approach allows us to deliver market solutions before the technologies reach<br />
the market.<br />
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing<br />
startups. PMR’s collaborative environment is committed to building industry-specific solutions <strong>by</strong><br />
transforming data from multiple streams into a strategic asset.<br />
Contact Us:<br />
Persistence <strong>Market</strong> Research<br />
90 Sate Street, Suite 700 Albany, NY 12207<br />
Tel: +1-518-618-1030<br />
Email: sales@persistencemarketresearch.com<br />
Website: http://www.persistencemarketresearch.com/<br />
media@persistencemarketresearch.com<br />
Stay updated with our official Blog: http://pmrblog.com<br />
<strong>North</strong> America <strong>Wound</strong> <strong>Debridement</strong> <strong>Products</strong> <strong>Market</strong> <strong>by</strong> <strong>2024</strong>
Change language